FindTrial
Sign In

Study on the Application Effect of Midazolam Combined with Sufentanil in Bronchoscopy Examination

Study on the Application Effect of Midazolam Combined with Sufentanil in Bronchoscopy Examination

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095732
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease of respiratory system

Interventions

Sober sedation group:10 minutes before bronchoscopy, midazolam 0.03mg/kg and Sufentanil (0.1ug/kg) were injected intravenously (midazolam injection 2ml/10mg, Sufentanil 50ug/10ml), respectively
control group:None

Sponsors

Chaohu Hospital affiliated to Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) There are indications for fiberoptic bronchoscopic alveolar lavage

Exclusion criteria

Exclusion criteria: (1) 85 years old; (2) Severe respiratory failure, decompensated heart failure, severe hypertension (systolic blood pressure (BP) > 180 mmHg or diastolic blood pressure > 100 mmHg) and other complications; (3) requires general anesthesia; (4) Refusal of consent.

Design outcomes

Primary

MeasureTime frame
Post-patient evaluation of pain score at the end of patient examination;—

Secondary

MeasureTime frame
Assistant rated facial pain scale score;The operator scored in visual simulation;—

Countries

China

Contacts

Public ContactMeng Fanliang

64 Chaohu North Road, Chaohu City, Hefei City, Anhui Province

13966337677@163.com+86 139 6633 7677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026